Apalutamide added to ADT Means Improved Survival, Quality of Life

The addition of apalutamide to androgen deprivation therapy is well tolerated and significantly improves survival while maintaining health-related quality of life in men with prostate cancer.

Source: CancerNetwork - October 7, 2019 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news